Review



randomised phase 3 clinical trial  (Gilead Sciences)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Gilead Sciences randomised phase 3 clinical trial
    Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.
    Randomised Phase 3 Clinical Trial, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 15646 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/randomised+phase+3+clinical+trial/VEKLURY/pmc07828218-135-6-26
    Average 99 stars, based on 15646 article reviews
    randomised phase 3 clinical trial - by Bioz Stars, 2026-10
    99/100 stars

    Images

    1) Product Images from "Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm"

    Article Title: Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm

    Journal: Biomolecules

    doi: 10.3390/biom11010091

    Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.
    Figure Legend Snippet: Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.

    Techniques Used: Injection, Variant Assay

    Related Articles

    Injection:

    Article Title: Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
    Article Snippet: In a retrospective study, Stallmach et al. reported rapid mitigation of severe COVID-19 patients treated with infliximab, compared to a control COVID-19 group, who only received the best standard therapy [ ].In a retrospective study, Stallmach et al. reported rapid mitigation of severe COVID-19 patients treated with infliximab, compared to a control COVID-19 group, who only received the best standard therapy [ ].. Infliximab is currently tested in a randomised phase 3 clinical trial among other immune-modulating candidates for treating COVID-19 as an add-on therapy to the already approved remdesivir (Gilead Sciences, Inc., Foster City, CA, USA) (NCT04593940).. Also, adalimumab (AbbVie Inc., Lake Bluff, IL, USA) is currently being tested for its activity in reducing symptoms of COVID-19 patients at the Oxford Clinical Trials Research Unit in a trial started in July this year [ ].Also, adalimumab (AbbVie Inc., Lake Bluff, IL, USA) is currently being tested for its activity in reducing symptoms of COVID-19 patients at the Oxford Clinical Trials Research Unit in a trial started in July this year [ ].

    Variant Assay:

    Article Title: Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm
    Article Snippet: In a retrospective study, Stallmach et al. reported rapid mitigation of severe COVID-19 patients treated with infliximab, compared to a control COVID-19 group, who only received the best standard therapy [ ].In a retrospective study, Stallmach et al. reported rapid mitigation of severe COVID-19 patients treated with infliximab, compared to a control COVID-19 group, who only received the best standard therapy [ ].. Infliximab is currently tested in a randomised phase 3 clinical trial among other immune-modulating candidates for treating COVID-19 as an add-on therapy to the already approved remdesivir (Gilead Sciences, Inc., Foster City, CA, USA) (NCT04593940).. Also, adalimumab (AbbVie Inc., Lake Bluff, IL, USA) is currently being tested for its activity in reducing symptoms of COVID-19 patients at the Oxford Clinical Trials Research Unit in a trial started in July this year [ ].Also, adalimumab (AbbVie Inc., Lake Bluff, IL, USA) is currently being tested for its activity in reducing symptoms of COVID-19 patients at the Oxford Clinical Trials Research Unit in a trial started in July this year [ ].



    Similar Products

    randomised phase 3 clinical trial  (Gilead Sciences)
    99
    Gilead Sciences randomised phase 3 clinical trial
    Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.
    Randomised Phase 3 Clinical Trial, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/randomised+phase+3+clinical+trial/VEKLURY/pmc07828218-135-6-26
    Average 99 stars, based on 1 article reviews
    randomised phase 3 clinical trial - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.

    Journal: Biomolecules

    Article Title: Cytokines and Chemokines in SARS-CoV-2 Infections—Therapeutic Strategies Targeting Cytokine Storm

    doi: 10.3390/biom11010091

    Figure Lengend Snippet: Summary of selected therapeutic strategies targeting the cytokine storm in COVID-19 in phase 3 and 4 clinical trials registered on clinicaltrials.gov and clinicaltrialsregister.eu databases Abbreviations: SOC, standard of care; IMV, invasive mechanical ventilation; MV, mechanical ventilation; ICU, intensive care unit; ECMO, extracorporeal membrane oxygenation.

    Article Snippet: Infliximab is currently tested in a randomised phase 3 clinical trial among other immune-modulating candidates for treating COVID-19 as an add-on therapy to the already approved remdesivir (Gilead Sciences, Inc., Foster City, CA, USA) (NCT04593940).

    Techniques: Injection, Variant Assay